{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T12:46:28Z","timestamp":1790253988906,"version":"4.1.0"},"reference-count":28,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2018,8,9]],"date-time":"2018-08-09T00:00:00Z","timestamp":1533772800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0200923","type":"journal-article","created":{"date-parts":[[2018,8,9]],"date-time":"2018-08-09T17:50:03Z","timestamp":1533837003000},"page":"e0200923","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":26,"title":["Aryl hydrocarbon receptor (AHR) is a novel druggable pathway controlling malignant progenitor proliferation in chronic myeloid leukemia (CML)"],"prefix":"10.1371","volume":"13","author":[{"given":"Melanie","family":"Gentil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Hugues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Desterke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gladys","family":"Telliam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Sloma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4254-7509","authenticated-orcid":true,"given":"Lucas E. B.","family":"Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8654-5332","authenticated-orcid":true,"given":"Seda","family":"Baykal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerome","family":"Artus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Griscelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnes","family":"Guerci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyacinthe","family":"Johnson-Ansah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adlen","family":"Foudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annelise","family":"Bennaceur-Griscelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4861-0137","authenticated-orcid":true,"given":"Ali G.","family":"Turhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,8,9]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/S0140-6736(13)62120-0","article-title":"Chronic myeloid leukaemia","volume":"385","author":"JF Apperley","year":"2015","journal-title":"Lancet Lond Engl"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"713","DOI":"10.18632\/oncotarget.333","article-title":"Chronic myeloid leukemia stem cells in the era of targeted therapies: resistance, persistence and long-term dormancy","volume":"2","author":"J-C Chomel","year":"2011","journal-title":"Oncotarget"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1182\/blood.V97.7.2084","article-title":"BCR-ABL down-regulates the DNA repair protein DNA-PKcs","volume":"97","author":"E Deutsch","year":"2001","journal-title":"Blood"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"4583","DOI":"10.1182\/blood-2002-10-3011","article-title":"Down-regulation of BRCA1 in BCR-ABL-expressing hematopoietic cells","volume":"101","author":"E Deutsch","year":"2003","journal-title":"Blood"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/sj.onc.1209756","article-title":"Fusion tyrosine kinases: a result and cause of genomic instability","volume":"26","author":"ETP Penserga","year":"2007","journal-title":"Oncogene"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"3657","DOI":"10.1182\/blood-2011-02-335497","article-title":"Leukemic stem cell persistence in chronic myeloid leukemia patients with sustained undetectable molecular residual disease","volume":"118","author":"J-C Chomel","year":"2011","journal-title":"Blood"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"5565","DOI":"10.1182\/blood-2010-12-327437","article-title":"Persistence of leukemia stem cells in chronic myelogenous leukemia patients in prolonged remission with imatinib treatment","volume":"118","author":"S Chu","year":"2011","journal-title":"Blood"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/S1470-2045(10)70233-3","article-title":"Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trial","volume":"11","author":"F-X Mahon","year":"2010","journal-title":"Lancet Oncol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/sj.leu.2401730","article-title":"Biological effects induced by variable levels of BCR-ABL protein in the pluripotent hematopoietic cell line UT-7","volume":"14","author":"C Issaad","year":"2000","journal-title":"Leukemia"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"e68425","DOI":"10.1371\/journal.pone.0068425","article-title":"Flow cytometric quantification of all phases of the cell cycle and apoptosis in a two-color fluorescence plot","volume":"8","author":"C Vignon","year":"2013","journal-title":"PloS One"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1038\/leu.2008.392","article-title":"The hematopoietic stem cell in chronic phase CML is characterized by a transcriptional profile resembling normal myeloid progenitor cells and reflecting loss of quiescence","volume":"23","author":"I Bruns","year":"2009","journal-title":"Leukemia"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"6567","DOI":"10.1073\/pnas.082099299","article-title":"Diagnosis of multiple cancer types by shrunken centroids of gene expression","volume":"99","author":"R Tibshirani","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1093\/bioinformatics\/bti394","article-title":"MADE4: an R package for multivariate analysis of gene expression data","volume":"21","author":"AC Culhane","year":"2005","journal-title":"Bioinforma Oxf Engl"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1093\/bioinformatics\/bts366","article-title":"GO-Elite: a flexible solution for pathway and ontology over-representation","volume":"28","author":"AC Zambon","year":"2012","journal-title":"Bioinforma Oxf Engl"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1038\/nprot.2007.324","article-title":"Integration of biological networks and gene expression data using Cytoscape","volume":"2","author":"MS Cline","year":"2007","journal-title":"Nat Protoc"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"A Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1038\/nature07016","article-title":"PML targeting eradicates quiescent leukaemia-initiating cells","volume":"453","author":"K Ito","year":"2008","journal-title":"Nature"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/ng.389","article-title":"Loss of the Alox5 gene impairs leukemia stem cells and prevents chronic myeloid leukemia","volume":"41","author":"Y Chen","year":"2009","journal-title":"Nat Genet"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"3550","DOI":"10.1182\/blood-2011-12-397554","article-title":"Essential role for Stat5a\/b in myeloproliferative neoplasms induced by BCR-ABL1 and JAK2(V617F) in mice","volume":"119","author":"C Walz","year":"2012","journal-title":"Blood"},{"issue":"35","key":"ref20","doi-asserted-by":"crossref","first-page":"22708","DOI":"10.1074\/jbc.273.35.22708","article-title":"A direct interaction between the aryl hydrocarbon receptor and retinoblastoma protein. Linking dioxin signaling to the cell cycle","volume":"273","author":"NL Ge","year":"1998","journal-title":"J Biol Chem"},{"issue":"4","key":"ref21","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.bcp.2008.10.001","article-title":"The aryl hydrocarbon receptor has a normal function in the regulation of hematopoietic and other stem\/progenitor cell populations.","volume":"77","author":"KP Singh","year":"2009","journal-title":"Biochem Pharmacol"},{"issue":"12","key":"ref22","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/nrc3846","article-title":"Aryl hydrocarbon receptor ligands in cancer: friend and foe","author":"IA Murray","year":"2014","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"ref23","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.immuni.2017.12.012","article-title":"Regulation of the Immune Response by the Aryl Hydrocarbon Receptor","volume":"48","author":"C Guti\u00e9rrez-V\u00e1zquez","year":"2018","journal-title":"Immunity"},{"issue":"5997","key":"ref24","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1126\/science.1191536","article-title":"Aryl hydrocarbon receptor antagonists promote the expansion of human hematopoietic stem cells.","volume":"329","author":"AE Boitano","year":"2010","journal-title":"Science"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1089\/scd.2010.0333","article-title":"Aryl hydrocarbon receptor-null allele micehave hematopoietic stem\/progenitor cells with abnormal characteristics and functions","volume":"20","author":"KP Singh","year":"2011","journal-title":"Stem Cells Dev"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1089\/scd.2013.0346","article-title":"Loss of aryl hydrocarbon receptor promotes gene changes associated with premature hematopoietic stem cell exhaustion and development of a myeloproliferative disorder in aging mice","volume":"23","author":"KP Singh","year":"2014","journal-title":"Stem Cells Dev"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/leu.2012.196","article-title":"Ex vivo expansion of normal and chronic myeloid leukemic stem cells without functional alteration using a NUP98HOXA10homeodomain fusion gene","volume":"27","author":"I Sloma","year":"2013","journal-title":"Leukemia"},{"key":"ref28","first-page":"237","article-title":"Fibroblast growth factor signaling promotes physiological bone remodeling and stem cell self-renewal","volume":"20","author":"T Itkin","year":"2013","journal-title":"Curr Opin Hematol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0200923","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,7]],"date-time":"2020-11-07T14:24:20Z","timestamp":1604759060000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0200923"}},"subtitle":[],"editor":[{"given":"Persio","family":"Dello Sbarba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,8,9]]},"references-count":28,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2018,8,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0200923","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,9]]}}}